Spots Global Cancer Trial Database for A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
Official Title: An Open Label, Multi-cohort, Multicenter Phase II Study to Evaluate the Efficacy and Safety of Envofolimab in Combination With BD0801 Injection With/Without Chemotherapy in Patients With Advanced Solid Tumors
Study ID: NCT05148195
Conditions
Study Description
Brief Summary: This is an open label, multi-cohort, multicenter Phase II study, the purpose of this study is to assess the efficacy and safety of envofolimab in combination with BD0801 injection with/without chemotherapy for the treatment of advanced solid tumors
Detailed Description: The efficacy of immune checkpoint inhibitors combined with antivascular agents has been preliminarily demonstrated in a variety of solid tumors. Based on the huge clinical needs, the efficacy of envofolimab combined with BD0801 in patients with advanced hepatocellular carcinoma, non-small cell lung cancer and advanced colorectal cancer deserves further exploration.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Beijing Cancer Hospital, Beijing, , China
The First Affiliated Hospital of Bengbu Medical College, Bengbu, , China
Jilin Cancer Hospital, Changchun, , China
Hunan Cancer Hospital, Changsha, , China
Sichuan Cancer Hospital, Chengdu, , China
Dezhou People'S Hospital, Dezhou, , China
First Affiliated Hospital of Gannan Medical Universit, Ganzhou, , China
Nanfang Hospital of Southern Medical University, Guangzhou, , China
Sun Yat-sen University affiliated with the Sixth Hospital, Guangzhou, , China
Sun Yat-sen University Cancer Center, Guangzhou, , China
Shaw Hospital Affiliated to Medical College of Zhejiang Universit, Hangzhou, , China
Zhejiang Provincial People'S Hospital, Hangzhou, , China
Harbin Medical University Cancer Hospital, Harbin, , China
Anhui Chest Hospital, Hefei, , China
Anhui Provincial Cancer Hospital, Hefei, , China
The First Affliated Hospital Of Anhui Medical University, Hefei, , China
Shandong Cancer Hospital, Jinan, , China
Mianyang Central Hospital, Mianyang, , China
Liaoning Cancer Hospital, Shenyang, , China
The Fourth Hospital of Hebei Medical University, Shijia Zhuang, , China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, , China
Yantai Yuhuagnding Hospital, Yantai, , China
Henan Cancer Hospital, Zhengzhou, , China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, , China
Contact Details
Name: Zhengguang Lv
Affiliation: Jiangsu Simcere Pharmaceutical Co., Ltd.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
